Time Pharmaceuticals Signs NEPSE Agreement for Institutional Share Sale

Time Pharmaceuticals Limited, based in Gaindakot, Nawalparasi, has signed an agreement with the Nepal Stock Exchange (NEPSE) to conduct a book-building process for issuing 4,34,600 ordinary shares at Rs. 100 each for eligible institutional investors. This follows regulations set by the Securities Board of Nepal and relevant directives for securities issuance and allocation.

The company plans to raise Rs. 10.86 crore by issuing 10,86,500 shares, with 40% allocated to institutional investors via book-building and the remaining 60% offered to the general public through a public issue. After this issuance, the company’s total paid-up capital will be Rs. 53 crore.

Time Pharmaceuticals, in operation for over 30 years, has its head office in Gaindakot, a production plant in Gaindakot, and a marketing office in Lalitpur, employing around 300 staff and producing over 200 quality medicines certified under GMP standards.